← Evidence map

ArticleNature medicine2018

SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo.

Sara Mainardi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

195 papers cite itlatest 60 shown

2018
…
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29808006